Cargando…

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

Detalles Bibliográficos
Autores principales:	Ohtaki, Yuichiro, Uchiyama, Kan, Kamiya, Hirotaka, Moriizumi, Eri, Yamada, Moe, Aoki, Yuma, Watanabe, Toshimune, Kiryu, Sachie, Suzuki, Shizuka, Matsumoto, Yoshihiro, Ito, Zensho, Ohkusa, Toshifumi, Koido, Shigeo, Saruta, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896661/ https://www.ncbi.nlm.nih.gov/pubmed/36732723 http://dx.doi.org/10.1186/s12876-022-02608-z

Ejemplares similares

The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis
por: Yuichiro, Ohtaki, et al.
Publicado: (2022)

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease
por: Suzuki, Shizuka, et al.
Publicado: (2023)

The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions
por: Koido, Shigeo, et al.
Publicado: (2022)

Cancerous pericarditis presenting as cardiac tamponade in a 68-year-old man with pancreatic adenocarcinoma: a case report
por: Kiryu, Sachie, et al.
Publicado: (2020)

Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
por: Kiryu, Sachie, et al.
Publicado: (2021)

A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD)
por: Odahara, Shunichi, et al.
Publicado: (2015)

Growth of various obligate and facultative anaerobic intestinal bacteria in cell culture medium under aerobic and anaerobic culture conditions
por: OHKUSA, Toshifumi, et al.
Publicado: (2022)

Characterisation of blood microbiota in patients with liver cirrhosis
por: Kajihara, Mikio, et al.
Publicado: (2019)

Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model
por: Takakura, Kazuki, et al.
Publicado: (2015)

Metagenomic analyses of the gut microbiota associated with colorectal adenoma
por: Saito, Keisuke, et al.
Publicado: (2019)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

Long-term outcomes of antibiotic combination therapy for ulcerative colitis
por: Nishikawa, Yuriko, et al.
Publicado: (2021)

Gut Microbiota and Chronic Constipation: A Review and Update
por: Ohkusa, Toshifumi, et al.
Publicado: (2019)

Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma
por: Ito, Zensho, et al.
Publicado: (2017)

Hepatic Angiosarcoma Associated with Esophageal Variceal Hemorrhage
por: Ito, Zensho, et al.
Publicado: (2016)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
por: Koido, Shigeo, et al.
Publicado: (2010)

Cancer Vaccine by Fusions of Dendritic and Cancer Cells
por: Koido, Shigeo, et al.
Publicado: (2009)

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
por: Ogata, Haruhiko, et al.
Publicado: (2017)

Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation
por: Koido, Shigeo, et al.
Publicado: (2013)

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
por: Ogata, Haruhiko, et al.
Publicado: (2017)

Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
por: Koido, Shigeo, et al.
Publicado: (2011)

Acute Pancreatitis due to pH-Dependent Mesalazine That Occurred in the Course of Ulcerative Colitis
por: Arai, Yoshinori, et al.
Publicado: (2011)

Mesalazine-induced renal calculi
por: Jacobsson, Henrik, et al.
Publicado: (2013)

Myocarditis Related to the Use of Mesalazine
por: Kyriakou, Michaela, et al.
Publicado: (2023)

Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles
por: Lau, Esther T. L., et al.
Publicado: (2013)

Randomised controlled trial of mesalazine in IBS
por: Barbara, Giovanni, et al.
Publicado: (2016)

Long-Term Alteration of Intestinal Microbiota in Patients with Ulcerative Colitis by Antibiotic Combination Therapy
por: Koido, Shigeo, et al.
Publicado: (2014)

Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
por: Koido, Shigeo, et al.
Publicado: (2010)

Insoluble Fiber in Young Barley Leaf Suppresses the Increment of Postprandial Blood Glucose Level by Increasing the Digesta Viscosity
por: Takano, Akira, et al.
Publicado: (2013)

Impact of Bifidobacterium adolescentis in patients with abdominal aortic aneurysm: a cross-sectional study
por: ITO, Eisaku, et al.
Publicado: (2022)

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
por: Stolfi, Carmine, et al.
Publicado: (2012)

Mesalazine-induced myocarditis: a case report
por: Radhakrishnan, Shiva T., et al.
Publicado: (2018)

Repurposing mesalazine against cardiac fibrosis in vitro
por: Hoffmann, Maximilian, et al.
Publicado: (2020)

Mesalazine-induced myopericarditis: a case report
por: Shergill, Simran
Publicado: (2020)

Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
por: Chen, Junyu, et al.
Publicado: (2022)

Nanoparticles Obtained from Zein for Encapsulation of Mesalazine
por: Lima, Izabela Borges C., et al.
Publicado: (2022)

Mesalazine-induced myopericarditis: a case series
por: Andrei, Valentina, et al.
Publicado: (2023)

Fusions between dendritic cells and whole tumor cells as anticancer vaccines
por: Koido, Shigeo, et al.
Publicado: (2013)

The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
por: Takakura, Kazuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1al4r2ps1eh1ofvrn4j24cq0vr